These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28830741)

  • 1. Effects of Omega-3 in the treatment of violent schizophrenia patients.
    Qiao Y; Mei Y; Han H; Liu F; Yang XM; Shao Y; Xie B; Long B
    Schizophr Res; 2018 May; 195():283-285. PubMed ID: 28830741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized controlled study of the efficacy of six-month supplementation with concentrated fish oil rich in omega-3 polyunsaturated fatty acids in first episode schizophrenia.
    Pawełczyk T; Grancow-Grabka M; Kotlicka-Antczak M; Trafalska E; Pawełczyk A
    J Psychiatr Res; 2016 Feb; 73():34-44. PubMed ID: 26679763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia.
    Fenton WS; Dickerson F; Boronow J; Hibbeln JR; Knable M
    Am J Psychiatry; 2001 Dec; 158(12):2071-4. PubMed ID: 11729030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder.
    Krakowski MI; Czobor P; Citrome L; Bark N; Cooper TB
    Arch Gen Psychiatry; 2006 Jun; 63(6):622-9. PubMed ID: 16754835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability of long chain omega-3 polyunsaturated fatty acids from phospholipid-rich herring roe oil in men and women with mildly elevated triacylglycerols.
    Cook CM; Hallaråker H; Sæbø PC; Innis SM; Kelley KM; Sanoshy KD; Berger A; Maki KC
    Prostaglandins Leukot Essent Fatty Acids; 2016 Aug; 111():17-24. PubMed ID: 27151222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omega-3 supplementation from pregnancy to postpartum to prevent depressive symptoms: a randomized placebo-controlled trial.
    Vaz JDS; Farias DR; Adegboye ARA; Nardi AE; Kac G
    BMC Pregnancy Childbirth; 2017 Jun; 17(1):180. PubMed ID: 28599630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y.
    Thies F; Nebe-von-Caron G; Powell JR; Yaqoob P; Newsholme EA; Calder PC
    Am J Clin Nutr; 2001 Mar; 73(3):539-48. PubMed ID: 11237929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized placebo-controlled trial of an omega-3 fatty acid and vitamins E+C in schizophrenia.
    Bentsen H; Osnes K; Refsum H; Solberg DK; Bøhmer T
    Transl Psychiatry; 2013 Dec; 3(12):e335. PubMed ID: 24346133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omega-3 fatty acids in first-episode schizophrenia - a randomized controlled study of efficacy and relapse prevention (OFFER): rationale, design, and methods.
    Pawełczyk T; Grancow M; Kotlicka-Antczak M; Trafalska E; Gębski P; Szemraj J; Żurner N; Pawełczyk A
    BMC Psychiatry; 2015 May; 15():97. PubMed ID: 25934131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eicosapentaenoic and docosahexaenoic acids-rich fish oil supplementation attenuates strength loss and limited joint range of motion after eccentric contractions: a randomized, double-blind, placebo-controlled, parallel-group trial.
    Tsuchiya Y; Yanagimoto K; Nakazato K; Hayamizu K; Ochi E
    Eur J Appl Physiol; 2016 Jun; 116(6):1179-88. PubMed ID: 27085996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schizophrenic symptoms and dietary intake of n-3 fatty acids.
    Mellor JE; Laugharne JD; Peet M
    Schizophr Res; 1995 Dec; 18(1):85-6. PubMed ID: 8929766
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of ethyl-eicosapentaenoic acid omega-3 fatty acid supplementation on hot flashes and quality of life among middle-aged women: a double-blind, placebo-controlled, randomized clinical trial.
    Lucas M; Asselin G; Mérette C; Poulin MJ; Dodin S
    Menopause; 2009; 16(2):357-66. PubMed ID: 19034052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Schizophrenia and violence, incidence and risk factors: a Tunisian sample].
    Ellouze F; Ayedi S; Masmoudi S; Bakri L; Chérif W; Zramdini R; Largueche M; Amri H; Ben Abla T; M'rad MF
    Encephale; 2009 Sep; 35(4):347-52. PubMed ID: 19748371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of fish oil supplementation on serum phospholipid fatty acids profile during pregnancy: A double blind randomized controlled trial.
    Farshbaf-Khalili A; Mohamad-Alizadeh S; Darabi M; Hematzadeh S; Mehdizadeh A; Shaaker M; Ostadrahimi A
    Women Health; 2017 Feb; 57(2):137-153. PubMed ID: 27011294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. omega-3 Fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study.
    Zanarini MC; Frankenburg FR
    Am J Psychiatry; 2003 Jan; 160(1):167-9. PubMed ID: 12505817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schizophrenia and violence: study in a general psychiatric hospital with HCR-20 and MOAS.
    Meyer LF; Telles LEB; Mecler K; Soares ALAG; Alves RS; Valença AM
    Trends Psychiatry Psychother; 2018; 40(4):310-317. PubMed ID: 30570102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of omega-3 fatty acid-containing phospholipids on blood catecholamine concentrations in healthy volunteers: a randomized, placebo-controlled, double-blind trial.
    Hamazaki K; Itomura M; Huan M; Nishizawa H; Sawazaki S; Tanouchi M; Watanabe S; Hamazaki T; Terasawa K; Yazawa K
    Nutrition; 2005 Jun; 21(6):705-10. PubMed ID: 15925295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, randomized, placebo-controlled trial of n-3 versus n-6 fatty acid-based lipid infusion in atopic dermatitis.
    Mayser P; Mayer K; Mahloudjian M; Benzing S; Krämer HJ; Schill WB; Seeger W; Grimminger F
    JPEN J Parenter Enteral Nutr; 2002; 26(3):151-8. PubMed ID: 12005454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyunsaturated fatty acid supplementation for schizophrenia.
    Joy CB; Mumby-Croft R; Joy LA
    Cochrane Database Syst Rev; 2003; (2):CD001257. PubMed ID: 12804400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No Impact of Omega-3 Fatty Acid Supplementation on Symptoms or Hostility Among Patients With Schizophrenia.
    Qiao Y; Liu CP; Han HQ; Liu FJ; Shao Y; Xie B
    Front Psychiatry; 2020; 11():312. PubMed ID: 32372988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.